Disc Medicine announced plans to resubmit a New Drug Application to the FDA following successful Phase 3 trial results for bitopertin, an oral drug targeting erythropoietic protoporphyria, a rare inherited condition causing extreme light sensitivity. The trial met its primary and secondary endpoints, reviving hopes for FDA approval. This development could bring a new treatment option for patients with this rare disorder. The company is now preparing for the regulatory review process based on these promising results.
Disc Medicine's recent trial success is the focus, with Pluang's Health sector market snapshot as of Oct 19, 2026 22:21 WIB: Among 150 priced Health-sector US stocks tradable on Pluang, 73 rose and 70 fell today. Notable movers include SLS (SELLAS Life Sciences Group Inc. Common Stock) at USD 10.64 with a 1-day change of +6.61% and a typical hold time on Pluang of 4 days, RXRX (Recursion Pharmaceuticals Inc) at USD 3.64 with a 1-day change of +5.05% and a typical hold time of 21 days, and DYN (Dyne Therapeutics Inc. Common Stock) at USD 14.95 with a 1-day change of +4.91% and a typical hold time of 3 days.
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
The global migraine market is projected to expand at a 6% annual growth rate through 2036, driven by rising migraine prevalence, better diagnosis, and awareness. Innovative treatments beyond traditional CGRP inhibitors, including PACAP-targeted thera...
Miracles, a company specializing in personalized children's books where each child becomes the story's hero, has printed over 100,000 books for more than 45,000 families. The books are printed locally in Germany and delivered within a few days, offer...
Miracles, a personalized children's book maker, has printed more than 100,000 books, serving over 45,000 families. Each book features a unique 3D character of the child, created from a single photo, making the child the hero of the story. Books for U...
Roth Capital increased its price target for Chord Energy to $165 from $145 following strong Q3 2026 operational performance, including production exceeding forecasts and capital spending within budget. The company also executed $205 million in share ...
